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Objectives. We investigated individual- and neighborhood-level factors asso-
ciated with adolescent initiation of injection drug use. 
Methods. Injection drug users (IDUs) who had been injecting 2 to 5 years un-
derwent HIV testing and completed a sociobehavioral risk survey. Modeling tech-
niques accounting for intraneighborhood correlations were used in data analyses.
Results. Adolescent-initiating IDUs were less likely than adult-initiating IDUs to
report high-risk sex and injection behaviors and more likely to report high-risk net-
works. African American IDUs from neighborhoods with large percentages of
minority residents and low adult educational levels were more likely to initiate in-
jection during adolescence than White IDUs from neighborhoods with low per-
centages of minority residents and high adult education levels. 
Conclusions. Racial segregation and neighborhood-level educational attain-
ment must be considered when drawing inferences about age at initiation of in-
jection drug use and related high-risk behaviors. (Am J Public Health. 2005;95:
689–695. doi:10.2105/AJPH.2003.02178)
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)Young or recent-onset injection drug users
(IDUs) continue to be at high risk for acquir-
ing hepatitis B and C virus infection as well as
HIV.1–9 Although drug dependence is classi-
fied as a psychiatric disorder, abundant evi-
dence suggests that injection drug use is also
a social problem, one that characterizes many
disadvantaged settings both in the United
States and abroad.10–15 Therefore, it is con-
ceivable that social processes are involved in
the onset of injection, namely factors occur-
ring at an individual level that may, in fact, be
shaped by contextual-level factors (e.g., neigh-
borhood characteristics). According to this
premise, ignoring contextual or “neighbor-
hood” factors can lead to an incomplete un-
derstanding of the relation between individ-
ual risk factors and disease. However, most
studies of HIV risk behavior and onset of in-
jection drug use have focused exclusively on
individual-level risk factors.13,16–19
Research has shown that race/ethnicity
plays an important role in initiation of illicit
drug use, as well as risk for drug-related in-
fectious disease such as HIV. Specifically,
White drug users initiate illicit non-injection
and injection drug use at a younger age than
African Americans.18,20–23 In addition, studies
comparing individuals who do not use injec-
tion drugs and those who do have shown that
White drug users are more likely to use injec-
tion drugs than African American drug
users.18,20 However, they are less likely to
contract HIV.24–28 This racial/ethnic differ-
ence in risk of HIV infection has not been
fully explained. 
Understanding the interrelationships
between onset of injection drug use, race/
ethnicity, and subsequent risk for HIV is criti-
cal to the implementation of targeted inter-
ventions designed to reduce not only risk of
infectious disease but the onset of a lifelong
injection habit. In addition, given the in-
creased risk of infectious disease immediately
after the onset of injection drug use,1,3,6–8,19
determining the ways in which onset of use
and race/ethnicity affect early high-risk be-
haviors (i.e., those occurring immediately
after initiation of injection drug use) is a
viable next step.
The racial/ethnic differences that exist in
illicit drug use and related infectious diseases
may be due in part to social and contextual in-
fluences, which have received limited atten-
tion. Until recently, epidemiological research
had not examined race as a social and contex-
tual variable.29 Residents of certain neighbor-
hoods may find themselves at increased risk
of initiating injection drug use as a result of
the socioeconomic structure of their environ-
ment, independent of their individual race or
socioeconomic status. For example, in impov-
erished neighborhoods drugs may be more
available,10 levels of psychological distress may
be higher,30 and there may be fewer alterna-
tive activities (e.g., employment opportunities). 
On the basis of our earlier findings re-
garding neighborhood characteristics and dis-
tress,31 we hypothesize that onset of injection
drug use may be influenced by the racial
composition, poverty level, or employment
level of a given neighborhood. In addition,
given the body of research illustrating the re-
lationship between high-risk networks and il-
licit drug use as well as HIV prevalence
rates,32–38 neighborhood characteristics may
also affect individual-level risk behaviors (e.g.,
membership in high-risk networks) that follow
the onset of injection drug use.
To expand on our previous work on racial/
ethnic differences in onset of injection drug
use,18,21,39,40 we investigated the effects of
race/ethnicity and high-risk behaviors on
early initiation both before and after control-
ling for neighborhood-level characteristics.
We also examined possible pathways through
which neighborhood characteristics could in-
teract with race to affect age at initiation.
Such analyses may illuminate avenues for
community-level prevention interventions
among vulnerable populations facing poten-
tially high burdens of drug dependence and
blood-borne or sexually acquired infections.
METHODS
Study Population
Between July 1997 and May 1999, adoles-
cent and young adult IDUs between the ages
of 15 and 30 years were recruited into a pro-
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spective study of HIV infection conducted in
Baltimore (the Risk Evaluation and Assess-
ment of Community Health [REACH II]
Study). As described elsewhere,21 a recre-
ational vehicle (mobile clinic) and a clinic
were employed as study venues. Briefly, out-
reach workers approached drug users in
neighborhoods where drugs were bought or
used (or both) and encouraged them to visit
the stationary or mobile research site. 
To be eligible for the study, individuals had
to be between 15 and 30 years of age, had to
have injected drugs for a period of 5 years or
less before study entry, and had to report at
least one injection in the 6 months before
study entry. Participants’ ages were verified
through photo identifications that included
their birth date (driver’s license or state iden-
tification) or were accompanied by official
documents containing their name and birth
date (court, medical, or other social services
paperwork). Injection status was verified
through the presence of stigmata or “track
marks” (scarring along the veins arms where
injection occurs), commonly observed among
IDUs. At each scheduled study visit, a modest
remuneration was provided.
Data Collection
Eligible and consenting participants com-
pleted a structured interview conducted pri-
vately by trained staff. Along with pretest
HIV counseling, venipunctures were con-
ducted after the interview, and participants
were offered referrals for medical and social
services. After 2 weeks, at the HIV test result
visit, participants were provided additional
counseling and referrals. This study also in-
cluded 6-month and 12-month follow-up vis-
its in which participants completed inter-
viewer-administered questionnaires and
venipunctures; only baseline data were in-
cluded in the present analyses.
Sociodemographic and serologic factors ex-
amined included age, gender, race/ethnicity,
education level, juvenile arrest record, and
HIV serostatus. We also assessed distance
from the nearest needle exchange program
(NEP) site in an attempt to determine the rela-
tionship between having an NEP close by and
initiating injection drug use at a young age. 
Variables related to early sex practices (in-
cluding age at first sexual activity, trading sex
for drugs, and condom use) and drug injec-
tion practices (e.g., sharing injection equip-
ment, attending shooting galleries, injecting
within a high-risk network, and having ever
introduced someone to injection) were exam-
ined via reconstructions of participants’ be-
havioral histories. These reconstructions en-
tailed retrospective year-by-year assessments,
spanning year of injection initiation to study
entry, involving the use of a previously vali-
dated interviewer strategy (as described else-
where41,42). They began with behaviors occur-
ring in the most remote period and moved
forward in time to the most recent period. 
Data on age at initiation of injection drug
use were collected, and initiation was the out-
come variable in the present analyses. HIV
antibodies were detected via enzyme-linked
immunosorbent assays (Ortho Diagnostics,
Raritan, NJ) and confirmed with Western Blot
tests (Ortho Diagnostics).
Individual-Level Variables
In accordance with the guidelines of the
American Academy of Pediatrics, a cutpoint
for age at initiation of injection drug use of
21 years was used to distinguish adolescents
from young adults. Racial/ethnic categories
were defined as African American, White,
and “other” (the latter accounting for less
than 5% of the total study population). Edu-
cation level was dichotomized as having
dropped out or not dropped out of high
school; dropouts were defined as those 18
years or older who reported that they had
completed only “some” high school or those
aged 15 to 17 years who reported that their
highest grade completed was 8th grade or
below (only 2 participants met the latter crite-
rion). Distance from an NEP site was dichoto-
mized as 1 mile (1.6 km) or more than 1 mile
from such a site, and juvenile arrest was di-
chotomized as ever versus never.
Factors examined in association with early
high-risk sex included trading of sex for drugs
during the first year of initiating injection
drug use (yes or no), condom use during the
first year of initiation (not always vs always),
and age at first sexual experience (13 years or
younger vs more than 13 years). Early injec-
tion practices examined included sharing in-
jection equipment during the first year of ini-
tiating injection drug use, attending a
shooting gallery to inject drugs, and injecting
within a high-risk network. On the basis of
previous research,36,43 an injecting network
was considered high risk if (1) an IDU in-
jected with 1 or more other IDUs during the
first injection year, (2) at least one of those in-
dividuals was not a personal acquaintance of
the IDU, and (3) the number of injecting part-
ners changed from year 1 to year 2 (suggest-
ing an unstable network). Because of the in-
clusion of this social network variable, the
study population was restricted to individuals
who had injected for at least 2 years.
Neighborhood-Level Variables
Recruitment sites, selected as the neighbor-
hoods where participants had grown up or
currently resided, were geocoded to partici-
pants’ census tracts. These sites were chosen
as opposed to home addresses because ap-
proximately 30% of the study population re-
ported being homeless or not having an ad-
dress. Among those who were able to provide
a home address, 85% lived in the neighbor-
hood where they were recruited. 
Using Summary Tape File 3A from the
1990 US Census,44 we obtained data on cen-
sus tract variables representing education, em-
ployment, percentage of minority residents,
and poverty level. Neighborhood education
level was dichotomized as neighborhoods in
which 45% or fewer of adult residents had or
did not have at least a high school or general
equivalency diploma (based on the 75th per-
centile of the distribution of the overall popula-
tion). Neighborhood employment level, defined
as the percentage of people 16 years or older
reporting being employed, was specified as a
continuous variable. Neighborhood racial/
ethnic composition was dichotomized as neigh-
borhoods in which 75% or more of residents
identified or did not identify themselves with a
minority racial/ethnic group (based on the
mean distribution of the overall population).
Nearly all (99%) of the minority residents in
these census tracts were African American.
Neighborhood poverty rate was defined as the
percentage of neighborhood residents living
below the poverty level45; this variable was di-
chotomized as 40% or more versus less than
40% of the population being classified as
below the poverty level (based on the median
of the distribution of the overall population).
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TABLE 1—Sociodemographic and Serologic Characteristics Associated With Adolescent
Initiation Among Recent-Onset Injection Drug Users (n=144)
Initiation Age ≤ 21 y, Odds Ratio
No. (%) No. (%) (95% Confidence Interval)
Race
African American 91 (63) 34 (37) 0.21* (0.21, 0.45)
White 53 (37) 39 (74) 1
Gender 
Female 86 (60) 39 (45) 0.59 (0.30, 1.05)
Male 58 (40) 34 (59) 1
Education level
Less than high school 86 (60) 47 (55) 1.58 (0.80, 3.09)
High school or more 58 (40) 26 (45) 1
Juvenile arrest
Yes 27 (19) 19 (70) 2.77* (1.12, 6.83)
No 117 (81) 46 (54) 1
Distance from needle exchange program 
≤ 1 mi 75 (52) 34 (45) 0.65 (0.44, 1.98)
> 1 mi 68 (48) 38 (56) 1
HIV serostatus
Positive 10 (15) 7 (47) 0.84 (0.29, 2.44)
Negative 129 (90) 66 (51) 1




To compare sociodemographic factors, HIV
seropositivity rates, and early high-risk behav-
iors (i.e., behaviors occurring within the first
year or 2 years of injection initiation) associ-
ated with adolescent initiation of injection
drug use, we calculated frequencies, means, or
medians for each variable of interest as appro-
priate. As a means of assessing interactions,
distributions of individual and neighborhood
characteristics were examined for each racial
group according to age of initiation. Depend-
ing on the variable in question, we deter-
mined statistically significant differences using
either t tests or χ2 analyses.
To assess the magnitude of the association
between race and age at initiation, we fit sev-
eral models using backward elimination. First,
we fit logistic regression models to estimate
the crude association between age at initia-
tion and each individual and neighborhood
covariate. Second, we fit a logistic regression
model to estimate the association between
age at initiation and race after adjusting for
all individual covariates. Covariates selected
for model building were based on P values
below .10. Third, after eliminating nonsignifi-
cant covariates, we included the neighbor-
hood covariates in the model. 
Plausible 2-way and 3-way interaction
terms were examined through stratification,
tested, and entered one at a time in the main
effects model. We conducted analyses using
SUDAAN (Research Triangle Institute, Re-
search Triangle Park, NC) to account for in-
traneighborhood outcome correlations.46
Findings were almost identical when the SAS
GENMOD procedure was used, and thus we
present results obtained with SUDAAN.
RESULTS
Of the 276 IDUs screened, 226 (82%)
were eligible for REACH II according to the
study criteria, and 144 were included in the
present analyses (in which the population was
restricted to IDUs who had been injecting for
2–5 years); 51% of these individuals had ini-
tiated injection drug use during adolescence.
More than half of the study population was
African American (63%) and female (60%).
The median age was 25 years (range: 15–30
years), and the median age at initiation of in-
jection was 21 years (range: 10–28 years)
(Table 1). Those who had initiated injection
during adolescence were less likely than
young adult initiates to be African American
(odds ratio [OR]=0.21) and more likely to
have been arrested as a juvenile (OR=2.77).
There were no differences between adoles-
cent and young adult initiators with respect to
gender, HIV seroprevalence, or distance from
an NEP.
Table 2 shows that adolescent initiators
were twice as likely as young adults to report
their first sexual experience as having taken
place before they were 14 years of age
(OR=2.23). Frequencies of trading sex for
drugs and using condoms during the first year
after injection did not significantly differ ac-
cording to age at initiation. In terms of early
injection practices, adolescent initiators were
significantly less likely than young adult initia-
tors to share injection equipment during their
first year of injection drug use (OR=0.48).
Having a high-risk network, attending a
shooting gallery during the first year of use,
and subsequently introducing someone else
to injection drug use did not differ signifi-
cantly according to age at initiation.
In Table 3, we present the sociodemo-
graphic characteristics of the neighborhoods
of new IDUs associated that were associated
with adolescent versus young adult initiation.
In general, neighborhoods of new IDUs
tended to have fewer people 16 years or
older reporting employment, higher percent-
ages of minority residents, and lower educa-
tion levels. Also, in comparison with young
adult initiators, adolescent initiators tended to
reside in neighborhoods with lower percent-
ages of people living below the poverty level.
However, none of these associations achieved
statistical significance with regard to age at
initiation.
Table 4 presents results from the final mod-
els in which (1) only individual-level effects
were considered, and (2) both individual- and
neighborhood-level effects were considered.
The independent effect of having a high-risk
social network was substantially reduced by
20% when the 2 models were compared,
while the remaining independent effects of ju-
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TABLE 2—High-Risk Sexual and Injection Behaviors Associated With Adolescent Initiation
Among Recent-Onset Injection Drug Users (n=144)
Initiation Age ≤ 21 y, Odds Ratio
No. (%) No. (%) (95% Confidence Interval)
Age at first sexual activity, y
≤ 13 65 (45) 40 (62) 2.23* (1.14, 4.36)
> 13 79 (55) 33 (42) 1
Traded sex for drugs in year after initiation
Yes 43 (30) 17 (40) 0.53 (0.25, 1.09)
No 101 (55) 56 (55) 1
Condom use in year after initiation
Always 47 (33) 49 (57) 1.94* (0.95, 3.95)
Not always 58 (40) 24 (41) 1
Shared injection equipment in year after initiation
Yes 91 (63) 40 (44) 0.48* (0.24, 0.95)
No 53 (37) 33 (62) 1
Shooting gallery use in year after initiation
Yes 51 (35) 25 (49) 0.75 (0.37, 1.50)
No 93 (65) 48 (52) 1
High-risk network in 2-year period after initiationa
Yes 7 (5) 6 (86) 6.27* (0.74, 53.41)
No 137 (95) 67 (49) 1
Introduced someone to injection drug use
Yes 23 (16) 12 (52) 1.07 (0.44, 2.62)
No 121 (84) 61 (50) 1
aDefined as those reporting that they injected with more than 1 injecting partners in year 1, that at least one injecting
partner was a stranger, and that the number of injecting partners changed from year 1 to year 2.
*P ≤ .01.
TABLE 3—Sociodemographic Characteristics of Neighborhoods Associated With Age at
Initiation of Injection Drug Use (n=144)
No. (%) Initiation Age ≤ 21 y, No. (%) Odds Ratio (95% Confidence Interval)
Rate of adult employment, %a 143 (35.5) 72 (36.3) 1.58 (0.10, 25.97)
Minority composition, %
≥ 75 96 (66.7) 46 (63.0) 0.72 (0.45, 1.15)
< 75 48 (33.3) 27 (37.0) 1
High school education, % 
≥ 45 32 (22.2) 14 (19.2) 0.7 (0.34, 1.46)
< 45 112 (77.8) 59 (80.8) 1
Living below poverty level, %
≥ 40 70 (48.6) 33 (45.2) 0.76 (0.48, 1.21)
< 40 74 (51.4) 40 (54.8) 1
Note. Each neighborhood social characteristic is presented as the percentage of individuals in the zip code area from which a
particular individual was recruited.
aTreated as a continuous variable.
venile arrest, early syringe sharing, and con-
dom use remained unchanged. The model in-
cluding both individual and neighborhood
characteristics also showed that the individual
race effect was significantly modified by 2
neighborhood characteristics, education and
minority composition: African Americans who
lived in neighborhoods with high percentages
of minority residents, but in which 45% or
less of the adult population had a high school
education, were nearly 4 times more likely to
initiate use during adolescence than their
White counterparts living in neighborhoods
with lower minority percentages and with
more than 45% of the adult population hav-
ing a high school diploma.
DISCUSSION
The major finding of this study was that
features of the social environment, specifically
neighborhood minority composition and edu-
cation, are important in explaining the associ-
ation between age at initiation of injection
drug use and race/ethnicity. Specifically, rela-
tive to White injection drug users from neigh-
borhoods with lower percentages of minority
residents and higher educational levels, Afri-
can Americans from neighborhoods with high
percentages of minority residents and low ed-
ucational levels were more likely to initiate
use during adolescence. In neighborhoods
in which percentages of minority residents
and educational levels were high, there was
no significant difference in regard to race/
ethnicity and adolescent initiation. These
results suggest that, rather than race alone,
the interaction of neighborhood characteris-
tics and race determines age at initiation of
injection drug use.
Previous reports examining individual-
level effects have consistently shown that
White non-injection and injection drug users
are younger at initiation of use than their Af-
rican American counterparts.18,20–23 Al-
though published reports of neighborhood ef-
fects on initiation of drug use have been
sparse,10,47 evidence from other studies of
neighborhood effects on health outcomes
suggests mechanisms through which neigh-
borhood racial/ethnic composition and edu-
cational level may affect adolescent risk be-
haviors. Segregated neighborhoods in which
aggregate educational levels are low have
been considered to wield a “concentration ef-
fect.”48 That is, residents of these segregated
areas face a double burden: they have to
grapple with problems rooted in lack of in-
come or employment while dealing with the
social consequences of living in a place
where most people are poor. Similarly, sev-
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TABLE 4—Individual-Level and Hierarchical Logistic Regression Models of High-Risk
Behaviors and Neighborhood Effects Associated With Adolescent Initiation of Injection
Drug Use (n=144)
Individual Effects,a Individual and
Adjusted OR Neighborhood Effects,b
Characteristic (95% CI) Adjusted OR (95% CI)
AA vs White 0.18 (0.08, 0.40) 0.07 (0.05, 0.11)
Juvenile arrest: yes vs no 3.65 (1.31, 10.20) 3.72 (1.65, 8.40)
Shared vs did not share injection equipment in year after initiation 0.38 (0.16, 0.82) 0.38 (0.16, 0.91)
High-risk network during 2 years after initiation: yes vs no 17.52 (1.89, 162.47) 14.06 (5.98, 33.02)
Condom use in year after initiation: always vs not always 2.03 (0.89, 4.64) 2.08 (1.09, 3.99)
Minority composition: ≥ 75% vs < 75% . . . 0.87 (0.48, 1.60)
Completed HS: ≤ 45% vs > 45% . . . 1.67 (0.10, 26.62)
3-way interaction termc
AA ×≥ 75% Minority ×≤ 45% HS Diploma . . . 3.66 (2.11, 6.34)
AA ×≥ 75% Minority × > 45% HS Diploma . . . 1.56 (0.08, 31.30)
White × < 75% Minority × > 45% HS Diploma (reference) . . . . . .
Note. AA = African American; HS = high school.
aAdjusted for individual-level effects only, via multiple logistic regression.
bAdjusted for both individual- and neighborhood-level effects via SUDAAN modeling techniques.
cAll other joint effects of this interaction term demonstrated no associations.
eral studies have confirmed an association
between residential location and physical
health and mortality, independent of individ-
ual socioeconomic status.49,50
The consequences of poor neighborhood
living conditions can be far-reaching, and
their relationship with individual risk behav-
iors can operate through a number of mecha-
nisms. For example, social disorganization
theory has been used to conceptualize the re-
ciprocal influence of neighborhoods on social
behaviors. This theory rests on the impor-
tance of community in regard to maintaining
effective social controls.51 Lack of sufficient
social controls may lead to or exacerbate
crime, violence, and drug use.52 Residing in
neighborhoods characterized by social and
material deprivation may lead to social disor-
ganization, thereby influencing age at initia-
tion of injection drug use, particularly among
African Americans.
A second plausible mechanism through
which neighborhood characteristics can influ-
ence individual behavior is low social capital
or high income inequality, which can be char-
acterized by smaller proportions of budgets
being spent on education.53–55 Such social
disinvestment translates into poorer educa-
tional outcomes,54 as evidenced by higher
rates of unemployment, incarceration, and in-
come assistance. In turn, these factors have
been associated with community prevalence
rates of injection drug use.10 Moreover, resid-
ing in highly impoverished urban environ-
ments may influence drug initiation in that in-
dividuals are exposed to stressful situations,
distress, and feelings of hopelessness.56
It is noteworthy that, in race-specific
analyses (data not shown), we found that the
mean educational levels of neighborhoods
where individuals initiated drug use at a
young age were similar. However, White
adolescent-initiating drug users were pre-
dominantly recruited from neighborhoods
with higher employment levels, higher me-
dian household incomes, and low levels of
poverty, suggesting that the same educa-
tional attainment levels may not necessarily
translate into similar neighborhood condi-
tions for African Americans and Whites.
This finding is consistent with a previous
analysis of the 171 largest cities in the
United States indicating that the worst con-
texts in which Whites reside were consider-
ably better than the average contexts in
which African Americans reside.57
After adjustment for neighborhood-level
variables, some of the individual-level charac-
teristics remained independently associated
with adolescent initiation of injection drug
use. Specifically, while adolescent initiators re-
ported safer sex and injection practices, they
were more likely to report high-risk networks
after initiation. Several studies conducted
among IDUs have identified similar injection
network characteristics as leading to a high
risk of HIV infection.43,58–60 Our findings sug-
gest that adolescent initiators (during the
present study’s time frame), unlike young
adult initiators, may not have begun sharing
syringes until the second or third year after
initiation; such early changes in risk network
structure and composition may also differ ac-
cording to race.25 Thus, future research exam-
ining how IDUs’ networks change over a
high-risk period such as the first few years of
injection drug use,7,61 as well as comparing
network changes among IDUs and non-IDU
comparison groups, would further elucidate
these findings.
Neighborhood characteristics may also
have an influence on the particular effects of
one’s social network, as evidenced by the
20% reduction observed in our social net-
work estimate when neighborhood racial
composition and education were taken into
account. Hence, our findings provide support
for structural HIV prevention intervention
strategies targeting environments in which
there are high-risk social networks. However,
despite the strong independent association
observed between social networks and age at
initiation, our estimate may be somewhat un-
stable owing to the small number of individ-
uals who reported injecting in high-risk set-
tings at the onset of injection drug use (i.e.,
injecting with multiple partners they might
not have personally known). Thus, larger
studies examining race and social networks
among drug users from more heterogeneous
neighborhoods are warranted to determine
whether features of certain communities op-
erate the same in different socioeconomic
circumstances.
It is important to note a few drawbacks of
this study. First, it is evident that the use of
census tracts as crude proxies for neighbor-
hoods may be problematic, in that census
tracts may not be coterminous with neighbor-
hood boundaries. Although there is little
agreement regarding the optimal geographic
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area to use in studies such as this one, recent
research indicates that the smaller the geo-
graphic area (e.g., block groups), the smaller
the magnitude of bias due to aggregate proxy
data. However, studies have also shown only
minimal differences between estimates
derived from census tracts and block
groups.62–65 Thus, our results indicate that
neighborhood characteristics probably explain
interindividual variabilities in injection initia-
tion and subsequent risk behaviors not ex-
plained by individual-level factors. If bias oc-
curs as a result of using a larger (as opposed
to smaller) geographic area in defining neigh-
borhoods, our results probably represent un-
derestimates of the true effects.
Second, our small sample size and the ho-
mogeneity of neighborhood conditions from
which our participants were drawn must also
be acknowledged. The small sample size hin-
dered our ability to test multiple interactions,
and the lack of variation in characteristics be-
tween neighborhoods may have limited our
ability to detect significant contextual effects.
In this context, however, our findings proba-
bly represent underestimations of the contri-
bution of neighborhood conditions to age at
initiation of injection drug use.
Third, exposure levels may have been clas-
sified incorrectly as a result of biased recall or
difficulty recalling behavioral events. To mini-
mize recall bias, we referred to other memo-
rable biographical landmarks (i.e., pregnancy,
childbirth, time spent incarcerated, last school
grade attended) that could assist participants
in recalling the chronological sequence of
their high-risk behaviors. Also, our sample
was restricted to those with relatively short
injection histories, unlike previous studies in
which such year-by-year behavioral recon-
structions have been validated.41 In spite of
the measures just described, nondifferential
misclassification could have occurred, which
would tend to bias the associations observed
toward the null.42
Finally, our lack of data on long-term resi-
dential histories—an issue that has been the
focus of debate in regard to research on
neighborhood effects—could have been prob-
lematic. However, data from the 1990 US
census showed that 60% of Maryland resi-
dents had lived in the same house for the
past 5 years.44 Moreover, existing evidence
suggests that when people relocate, most tend
to move to neighborhoods similar to their for-
mer ones.50,63,65 Therefore, we believe that
the contextual effects observed here are likely
to be meaningful and real.
Our results suggest that neighborhood
characteristics contributed to the racial/ethnic
differences we observed. Although the degree
to which our findings are generalizable to
drug-using populations in other settings is un-
certain (indicating the need for additional
studies), they do, in fact, have implications for
both public health research and practice. For
example, research aimed at understanding the
determinants of injection risk behavior should
focus on both individual- and neighborhood-
level factors, as well as their interaction. From
a public health intervention perspective, it is
essential to understand that neighborhood
factors may have independent effects on indi-
vidual risks. Thus, interventions targeting
only individuals are bound to fall short, and
public health efforts involving multiple levels
of action may be more efficient and produce
sustainable benefits.
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